ArticleJCI insight2018
Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity.
Aarti Asnani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ArticleJCI insight2018
Aarti Asnani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.